Alexandria Kidney Center is a medicare approved dialysis facility center in Alexandria, Virginia and it has 36 dialysis stations. It is located in Alexandria City county at 4141 Duke Street, Alexandria, VA, 22304. You can reach out to the office of Alexandria Kidney Center at (703) 370-8250. This dialysis clinic is managed and/or owned by Fresenius Medical Care. Alexandria Kidney Center has the following ownership type - Profit. It was first certified by medicare in November, 1980. The medicare id for this facility is 492505 and it accepts patients under medicare ESRD program.
| Name | Alexandria Kidney Center |
|---|---|
| Location | 4141 Duke Street, Alexandria, Virginia |
| No. of Dialysis Stations | 36 |
| Medicare ID | 492505 |
| Managed By | Fresenius Medical Care |
| Ownership Type | Profit |
| Late Shifts | Yes |
| 4141 Duke Street, Alexandria, Virginia, 22304 | |
| (703) 370-8250 | |
News Archive
A study by the UPV/EHU has found that undocumented immigrants encounter structural and individual barriers linked to their social vulnerability when accessing public health services in the Basque Autonomous Community.
Amgen today announced top-line results of the Phase 3 EVOLVE (EValuation Of Cinacalcet HCl Therapy to Lower CardioVascular Events) trial, which evaluated Sensipar/Mimpara (cinacalcet) for the reduction of the risk of mortality and cardiovascular (CV) events among 3,883 patients with secondary hyperparathyroidism (HPT) and chronic kidney disease (CKD) receiving dialysis.
In a study published today in Genes & Development, Dr Christian Speck from the MRC Clinical Sciences Centre's DNA Replication group, in collaboration with Brookhaven National Laboratory (BNL), New York, reveal the intricate mechanisms involved in the enzyme that governs DNA duplication during cell division.
In an article in its "Building Resilience" series, IRIN examines the impact of HIV funding on health care systems in developing countries, writing, "Some have argued that the AIDS epidemic has helped generate an overall increase in health funding and mobilized an international push for more equitable health care access. But others maintain that the billions of donor dollars spent fighting HIV/AIDS in the last decade have done little to strengthen fragile national health systems."
› Verified 1 days ago
| NPI Number | 1033213905 |
| Organization Name | Bma Alexandria |
| Doing Business As | Bio-medical Applications Of Virginia, Inc. |
| Address | 4141 Duke St Alexandria, Virginia, 22304 |
| Phone Number | (703) 370-8250 |
News Archive
A study by the UPV/EHU has found that undocumented immigrants encounter structural and individual barriers linked to their social vulnerability when accessing public health services in the Basque Autonomous Community.
Amgen today announced top-line results of the Phase 3 EVOLVE (EValuation Of Cinacalcet HCl Therapy to Lower CardioVascular Events) trial, which evaluated Sensipar/Mimpara (cinacalcet) for the reduction of the risk of mortality and cardiovascular (CV) events among 3,883 patients with secondary hyperparathyroidism (HPT) and chronic kidney disease (CKD) receiving dialysis.
In a study published today in Genes & Development, Dr Christian Speck from the MRC Clinical Sciences Centre's DNA Replication group, in collaboration with Brookhaven National Laboratory (BNL), New York, reveal the intricate mechanisms involved in the enzyme that governs DNA duplication during cell division.
In an article in its "Building Resilience" series, IRIN examines the impact of HIV funding on health care systems in developing countries, writing, "Some have argued that the AIDS epidemic has helped generate an overall increase in health funding and mobilized an international push for more equitable health care access. But others maintain that the billions of donor dollars spent fighting HIV/AIDS in the last decade have done little to strengthen fragile national health systems."
› Verified 1 days ago
| Experience Measure | Provider | National Avg. |
|---|---|---|
| Patients who reported that nephrologists always communicated and cared for them. | 65% | 67% |
| Patients who reported that nephrologists usually communicated and cared for them. | 19% | 15% |
| Patients who reported that nephrologists sometimes or never communicated and cared for them. | 16% | 18% |
| Patients who gave their nephrologists a rating of 9 or 10 on a scale of 0 (worst possible) to 10 (best possible). | 50% | 60% |
| Patients who gave their nephrologists a rating of 7 or 8 on a scale of 0 (worst possible) to 10 (best possible). | 25% | 26% |
| Patients who gave their nephrologists a rating of 6 or less than 6 on a scale of 0 (worst possible) to 10 (best possible). | 25% | 14% |
News Archive
A study by the UPV/EHU has found that undocumented immigrants encounter structural and individual barriers linked to their social vulnerability when accessing public health services in the Basque Autonomous Community.
Amgen today announced top-line results of the Phase 3 EVOLVE (EValuation Of Cinacalcet HCl Therapy to Lower CardioVascular Events) trial, which evaluated Sensipar/Mimpara (cinacalcet) for the reduction of the risk of mortality and cardiovascular (CV) events among 3,883 patients with secondary hyperparathyroidism (HPT) and chronic kidney disease (CKD) receiving dialysis.
In a study published today in Genes & Development, Dr Christian Speck from the MRC Clinical Sciences Centre's DNA Replication group, in collaboration with Brookhaven National Laboratory (BNL), New York, reveal the intricate mechanisms involved in the enzyme that governs DNA duplication during cell division.
In an article in its "Building Resilience" series, IRIN examines the impact of HIV funding on health care systems in developing countries, writing, "Some have argued that the AIDS epidemic has helped generate an overall increase in health funding and mobilized an international push for more equitable health care access. But others maintain that the billions of donor dollars spent fighting HIV/AIDS in the last decade have done little to strengthen fragile national health systems."
› Verified 1 days ago
| Experience Measure | Provider | National Avg. |
|---|---|---|
| Patients who reported that dialysis center staff always communicated well, kept patients comfortable and pain-free as possible. | 50% | 62% |
| Patients who reported that dialysis center staff usually communicated, kept patients comfortable and pain-free as possible. | 26% | 20% |
| Patients who reported that dialysis center staff sometimes or never communicated, kept patients comfortable and pain-free. | 24% | 18% |
| Patients who gave their dialysis facility staff a rating of 9 or 10 on a scale of 0 (worst possible) to 10 (best possible). | 50% | 62% |
| Patients who gave their dialysis facility staff a rating of 7 or 8 on a scale of 0 (worst possible) to 10 (best possible). | 26% | 26% |
| Patients who gave their dialysis facility staff a rating of 6 or less than 6 on a scale of 0 (worst possible) to 10 (best possible). | 24% | 12% |
News Archive
A study by the UPV/EHU has found that undocumented immigrants encounter structural and individual barriers linked to their social vulnerability when accessing public health services in the Basque Autonomous Community.
Amgen today announced top-line results of the Phase 3 EVOLVE (EValuation Of Cinacalcet HCl Therapy to Lower CardioVascular Events) trial, which evaluated Sensipar/Mimpara (cinacalcet) for the reduction of the risk of mortality and cardiovascular (CV) events among 3,883 patients with secondary hyperparathyroidism (HPT) and chronic kidney disease (CKD) receiving dialysis.
In a study published today in Genes & Development, Dr Christian Speck from the MRC Clinical Sciences Centre's DNA Replication group, in collaboration with Brookhaven National Laboratory (BNL), New York, reveal the intricate mechanisms involved in the enzyme that governs DNA duplication during cell division.
In an article in its "Building Resilience" series, IRIN examines the impact of HIV funding on health care systems in developing countries, writing, "Some have argued that the AIDS epidemic has helped generate an overall increase in health funding and mobilized an international push for more equitable health care access. But others maintain that the billions of donor dollars spent fighting HIV/AIDS in the last decade have done little to strengthen fragile national health systems."
› Verified 1 days ago
| Experience Measure | Provider | National Avg. |
|---|---|---|
| Patients who reported that 'YES', their nephrologists and dialysis center staff provided them the information they needed to take care of them. | 74% | 80% |
| Patients who reported that 'NO', their nephrologists and dialysis center staff does not provided them the information they needed to take care of them. | 26% | 20% |
| Patients who gave their dialysis center a rating of 9 or 10 on a scale of 0 (worst possible) to 10 (best possible). | 49% | 68% |
| Patients who gave their dialysis center a rating of 7 or 8 on a scale of 0 (worst possible) to 10 (best possible). | 36% | 20% |
| Patients who gave their dialysis center a rating of 6 or less than 6 on a scale of 0 (worst possible) to 10 (best possible). | 15% | 12% |
News Archive
A study by the UPV/EHU has found that undocumented immigrants encounter structural and individual barriers linked to their social vulnerability when accessing public health services in the Basque Autonomous Community.
Amgen today announced top-line results of the Phase 3 EVOLVE (EValuation Of Cinacalcet HCl Therapy to Lower CardioVascular Events) trial, which evaluated Sensipar/Mimpara (cinacalcet) for the reduction of the risk of mortality and cardiovascular (CV) events among 3,883 patients with secondary hyperparathyroidism (HPT) and chronic kidney disease (CKD) receiving dialysis.
In a study published today in Genes & Development, Dr Christian Speck from the MRC Clinical Sciences Centre's DNA Replication group, in collaboration with Brookhaven National Laboratory (BNL), New York, reveal the intricate mechanisms involved in the enzyme that governs DNA duplication during cell division.
In an article in its "Building Resilience" series, IRIN examines the impact of HIV funding on health care systems in developing countries, writing, "Some have argued that the AIDS epidemic has helped generate an overall increase in health funding and mobilized an international push for more equitable health care access. But others maintain that the billions of donor dollars spent fighting HIV/AIDS in the last decade have done little to strengthen fragile national health systems."
› Verified 1 days ago
| Dialysis patients with Hemoglobin data | 72 |
| Medicare patients who had average hemoglobin (hgb) less than 10 g/dL | 14 |
| Medicare patients who had average hemoglobin (hgb) greater than 12 g/dL | 1 |
News Archive
A study by the UPV/EHU has found that undocumented immigrants encounter structural and individual barriers linked to their social vulnerability when accessing public health services in the Basque Autonomous Community.
Amgen today announced top-line results of the Phase 3 EVOLVE (EValuation Of Cinacalcet HCl Therapy to Lower CardioVascular Events) trial, which evaluated Sensipar/Mimpara (cinacalcet) for the reduction of the risk of mortality and cardiovascular (CV) events among 3,883 patients with secondary hyperparathyroidism (HPT) and chronic kidney disease (CKD) receiving dialysis.
In a study published today in Genes & Development, Dr Christian Speck from the MRC Clinical Sciences Centre's DNA Replication group, in collaboration with Brookhaven National Laboratory (BNL), New York, reveal the intricate mechanisms involved in the enzyme that governs DNA duplication during cell division.
In an article in its "Building Resilience" series, IRIN examines the impact of HIV funding on health care systems in developing countries, writing, "Some have argued that the AIDS epidemic has helped generate an overall increase in health funding and mobilized an international push for more equitable health care access. But others maintain that the billions of donor dollars spent fighting HIV/AIDS in the last decade have done little to strengthen fragile national health systems."
› Verified 1 days ago
Adult patinets who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be atleast 1.7, that means they are receiving right amount of dialysis. Pediatric patients who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be 1.8.
Higher percentages should be better.
| Adult patients getting regular hemodialysis at the center | 110 |
| Adult patient months included in Kt/V greater than or equal to 1.2 | 904 |
| Percentage of adult patients getting regular hemodialysis at the center | 96 |
News Archive
A study by the UPV/EHU has found that undocumented immigrants encounter structural and individual barriers linked to their social vulnerability when accessing public health services in the Basque Autonomous Community.
Amgen today announced top-line results of the Phase 3 EVOLVE (EValuation Of Cinacalcet HCl Therapy to Lower CardioVascular Events) trial, which evaluated Sensipar/Mimpara (cinacalcet) for the reduction of the risk of mortality and cardiovascular (CV) events among 3,883 patients with secondary hyperparathyroidism (HPT) and chronic kidney disease (CKD) receiving dialysis.
In a study published today in Genes & Development, Dr Christian Speck from the MRC Clinical Sciences Centre's DNA Replication group, in collaboration with Brookhaven National Laboratory (BNL), New York, reveal the intricate mechanisms involved in the enzyme that governs DNA duplication during cell division.
In an article in its "Building Resilience" series, IRIN examines the impact of HIV funding on health care systems in developing countries, writing, "Some have argued that the AIDS epidemic has helped generate an overall increase in health funding and mobilized an international push for more equitable health care access. But others maintain that the billions of donor dollars spent fighting HIV/AIDS in the last decade have done little to strengthen fragile national health systems."
› Verified 1 days ago
| Adult patients getting regular peritoneal dialysis at the center | 19 |
| Adult patient months included in Kt/V greater than or equal to 1.7 | 187 |
| Percentage of adult patients getting regular peritoneal dialysis at the center | 98 |
News Archive
A study by the UPV/EHU has found that undocumented immigrants encounter structural and individual barriers linked to their social vulnerability when accessing public health services in the Basque Autonomous Community.
Amgen today announced top-line results of the Phase 3 EVOLVE (EValuation Of Cinacalcet HCl Therapy to Lower CardioVascular Events) trial, which evaluated Sensipar/Mimpara (cinacalcet) for the reduction of the risk of mortality and cardiovascular (CV) events among 3,883 patients with secondary hyperparathyroidism (HPT) and chronic kidney disease (CKD) receiving dialysis.
In a study published today in Genes & Development, Dr Christian Speck from the MRC Clinical Sciences Centre's DNA Replication group, in collaboration with Brookhaven National Laboratory (BNL), New York, reveal the intricate mechanisms involved in the enzyme that governs DNA duplication during cell division.
In an article in its "Building Resilience" series, IRIN examines the impact of HIV funding on health care systems in developing countries, writing, "Some have argued that the AIDS epidemic has helped generate an overall increase in health funding and mobilized an international push for more equitable health care access. But others maintain that the billions of donor dollars spent fighting HIV/AIDS in the last decade have done little to strengthen fragile national health systems."
› Verified 1 days ago
An important goal of dialysis is to maintain normal levels of various minerals in the body, such as calcium. This shows the percentage of patients treated at Alexandria Kidney Center with elevated calcium levels.
| Patients with hypercalcemia | 141 |
| Hypercalcemia patient months | 1201 |
| Patients with Serumphosphor | 145 |
| Patients with Serumphosphor less than 3.5 mg/dL | 11 |
| Patients with Serumphosphor from 3.5 to 4.5 mg/dL | 26 |
| Patients with Serumphosphor from 4.6 to 5.5 mg/dL | 28 |
| Patients with Serumphosphor from 5.6 to 7 mg/dL | 23 |
| Patients with Serumphosphor greater than 7 mg/dL | 11 |
News Archive
A study by the UPV/EHU has found that undocumented immigrants encounter structural and individual barriers linked to their social vulnerability when accessing public health services in the Basque Autonomous Community.
Amgen today announced top-line results of the Phase 3 EVOLVE (EValuation Of Cinacalcet HCl Therapy to Lower CardioVascular Events) trial, which evaluated Sensipar/Mimpara (cinacalcet) for the reduction of the risk of mortality and cardiovascular (CV) events among 3,883 patients with secondary hyperparathyroidism (HPT) and chronic kidney disease (CKD) receiving dialysis.
In a study published today in Genes & Development, Dr Christian Speck from the MRC Clinical Sciences Centre's DNA Replication group, in collaboration with Brookhaven National Laboratory (BNL), New York, reveal the intricate mechanisms involved in the enzyme that governs DNA duplication during cell division.
In an article in its "Building Resilience" series, IRIN examines the impact of HIV funding on health care systems in developing countries, writing, "Some have argued that the AIDS epidemic has helped generate an overall increase in health funding and mobilized an international push for more equitable health care access. But others maintain that the billions of donor dollars spent fighting HIV/AIDS in the last decade have done little to strengthen fragile national health systems."
› Verified 1 days ago
The arteriovenous (AV) fistulae is considered long term vascular access for hemodialysis because it allows good blood flow, lasts a long time, and is less likely to get infected or cause blood clots than other types of access. Patients who don't have time to get a permanent vascular access before they start hemodialysis treatments may need to use a venous catheter as a temporary access.
| Patients included in arterial venous fistula and catheter summaries | 123 |
| Patient months included in arterial venous fistula and catheter summaries | 812 |
| Percentage of patients getting regular hemodialysis at the center that used an arteriovenous (AV) fistulae for their treatment | 69 |
| Percentage of patients receiving treatment through Vascular Catheter for 90 days/longer | 9 |
News Archive
A study by the UPV/EHU has found that undocumented immigrants encounter structural and individual barriers linked to their social vulnerability when accessing public health services in the Basque Autonomous Community.
Amgen today announced top-line results of the Phase 3 EVOLVE (EValuation Of Cinacalcet HCl Therapy to Lower CardioVascular Events) trial, which evaluated Sensipar/Mimpara (cinacalcet) for the reduction of the risk of mortality and cardiovascular (CV) events among 3,883 patients with secondary hyperparathyroidism (HPT) and chronic kidney disease (CKD) receiving dialysis.
In a study published today in Genes & Development, Dr Christian Speck from the MRC Clinical Sciences Centre's DNA Replication group, in collaboration with Brookhaven National Laboratory (BNL), New York, reveal the intricate mechanisms involved in the enzyme that governs DNA duplication during cell division.
In an article in its "Building Resilience" series, IRIN examines the impact of HIV funding on health care systems in developing countries, writing, "Some have argued that the AIDS epidemic has helped generate an overall increase in health funding and mobilized an international push for more equitable health care access. But others maintain that the billions of donor dollars spent fighting HIV/AIDS in the last decade have done little to strengthen fragile national health systems."
› Verified 1 days ago
The rate of hospitalization show you whether patients who were being treated regularly at a certain dialysis center were admitted to the hospital more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other centers.
| Standard Hospitalization Summary Ratio(SHR) Year | January, 2016 - December, 2016 |
| Patients in facility's Hospitalization Summary | 114 |
| Hospitalization Rate in facility | 196.6 (As Expected) |
| Hospitalization Rate: Upper Confidence Limit | 310.7 |
| Hospitalization Rate: Lower Confidence Limit | 133.3 |
News Archive
A study by the UPV/EHU has found that undocumented immigrants encounter structural and individual barriers linked to their social vulnerability when accessing public health services in the Basque Autonomous Community.
Amgen today announced top-line results of the Phase 3 EVOLVE (EValuation Of Cinacalcet HCl Therapy to Lower CardioVascular Events) trial, which evaluated Sensipar/Mimpara (cinacalcet) for the reduction of the risk of mortality and cardiovascular (CV) events among 3,883 patients with secondary hyperparathyroidism (HPT) and chronic kidney disease (CKD) receiving dialysis.
In a study published today in Genes & Development, Dr Christian Speck from the MRC Clinical Sciences Centre's DNA Replication group, in collaboration with Brookhaven National Laboratory (BNL), New York, reveal the intricate mechanisms involved in the enzyme that governs DNA duplication during cell division.
In an article in its "Building Resilience" series, IRIN examines the impact of HIV funding on health care systems in developing countries, writing, "Some have argued that the AIDS epidemic has helped generate an overall increase in health funding and mobilized an international push for more equitable health care access. But others maintain that the billions of donor dollars spent fighting HIV/AIDS in the last decade have done little to strengthen fragile national health systems."
› Verified 1 days ago
The rate of readmission show you whether patients who were being treated regularly at Alexandria Kidney Center were readmitted more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other dialysis centers.
| Standard Readmission Summary Ratio(SRR) Year | January, 2016 - December, 2016 |
| Readmission Rate in facility | 32.7 (As Expected) |
| Readmission Rate: Upper Confidence Limit | 43.5 |
| Readmission Rate: Lower Confidence Limit | 22.9 |
News Archive
A study by the UPV/EHU has found that undocumented immigrants encounter structural and individual barriers linked to their social vulnerability when accessing public health services in the Basque Autonomous Community.
Amgen today announced top-line results of the Phase 3 EVOLVE (EValuation Of Cinacalcet HCl Therapy to Lower CardioVascular Events) trial, which evaluated Sensipar/Mimpara (cinacalcet) for the reduction of the risk of mortality and cardiovascular (CV) events among 3,883 patients with secondary hyperparathyroidism (HPT) and chronic kidney disease (CKD) receiving dialysis.
In a study published today in Genes & Development, Dr Christian Speck from the MRC Clinical Sciences Centre's DNA Replication group, in collaboration with Brookhaven National Laboratory (BNL), New York, reveal the intricate mechanisms involved in the enzyme that governs DNA duplication during cell division.
In an article in its "Building Resilience" series, IRIN examines the impact of HIV funding on health care systems in developing countries, writing, "Some have argued that the AIDS epidemic has helped generate an overall increase in health funding and mobilized an international push for more equitable health care access. But others maintain that the billions of donor dollars spent fighting HIV/AIDS in the last decade have done little to strengthen fragile national health systems."
› Verified 1 days ago
Hemodialysis treatment requires direct access to the bloodstream, which can be an opportunity for germs to enter the body and cause infection. This information shows how often patients at Alexandria Kidney Center get infections in their blood each year compared to the number of infections expected for the center based on the national average.
| Standard Infection Summary Ratio(SIR) Year | January, 2016 - December, 2016 |
| Infection Rate in facility | .32 (As Expected) |
| SIR: Upper Confidence Limit | 1.07 |
| SIR: Lower Confidence Limit | .05 |
News Archive
A study by the UPV/EHU has found that undocumented immigrants encounter structural and individual barriers linked to their social vulnerability when accessing public health services in the Basque Autonomous Community.
Amgen today announced top-line results of the Phase 3 EVOLVE (EValuation Of Cinacalcet HCl Therapy to Lower CardioVascular Events) trial, which evaluated Sensipar/Mimpara (cinacalcet) for the reduction of the risk of mortality and cardiovascular (CV) events among 3,883 patients with secondary hyperparathyroidism (HPT) and chronic kidney disease (CKD) receiving dialysis.
In a study published today in Genes & Development, Dr Christian Speck from the MRC Clinical Sciences Centre's DNA Replication group, in collaboration with Brookhaven National Laboratory (BNL), New York, reveal the intricate mechanisms involved in the enzyme that governs DNA duplication during cell division.
In an article in its "Building Resilience" series, IRIN examines the impact of HIV funding on health care systems in developing countries, writing, "Some have argued that the AIDS epidemic has helped generate an overall increase in health funding and mobilized an international push for more equitable health care access. But others maintain that the billions of donor dollars spent fighting HIV/AIDS in the last decade have done little to strengthen fragile national health systems."
› Verified 1 days ago
Patients with anemia require blood transfusions if their anemia is not managed well by their dialysis center. This information shows whether Alexandria Kidney Center's rate of transfusions is better than expected, as expected, or worse than expected, compared to other centers that treat similar patients.
| Standard Transfusion Summary Ratio (STrR) Year | January, 2016 - December, 2016 |
| Patients in facility's Transfusion Summary | 90 |
| Transfusion Rate in facility | 47.1 (As Expected) |
| Transfusion Rate: Upper Confidence Limit | 90.8 |
| Transfusion Rate: Lower Confidence Limit | 26.5 |
News Archive
A study by the UPV/EHU has found that undocumented immigrants encounter structural and individual barriers linked to their social vulnerability when accessing public health services in the Basque Autonomous Community.
Amgen today announced top-line results of the Phase 3 EVOLVE (EValuation Of Cinacalcet HCl Therapy to Lower CardioVascular Events) trial, which evaluated Sensipar/Mimpara (cinacalcet) for the reduction of the risk of mortality and cardiovascular (CV) events among 3,883 patients with secondary hyperparathyroidism (HPT) and chronic kidney disease (CKD) receiving dialysis.
In a study published today in Genes & Development, Dr Christian Speck from the MRC Clinical Sciences Centre's DNA Replication group, in collaboration with Brookhaven National Laboratory (BNL), New York, reveal the intricate mechanisms involved in the enzyme that governs DNA duplication during cell division.
In an article in its "Building Resilience" series, IRIN examines the impact of HIV funding on health care systems in developing countries, writing, "Some have argued that the AIDS epidemic has helped generate an overall increase in health funding and mobilized an international push for more equitable health care access. But others maintain that the billions of donor dollars spent fighting HIV/AIDS in the last decade have done little to strengthen fragile national health systems."
› Verified 1 days ago
The rate of mortality show you whether patients who were being treated regularly at Alexandria Kidney Center lived longer than expected (better than expected), don’t live as long as expected (worse than expected), or lived as long as expected (as expected), compared to similar patients treated at other facilities.
| Standard Survival Summary Ratio(SIR) Year | January, 2013 - December, 2016 |
| Patients in facility's Survival Summary | 663 |
| Mortality Rate in facility | 18.7 (As Expected) |
| Mortality Rate: Upper Confidence Limit | 23.5 |
| Mortality Rate: Lower Confidence Limit | 14.6 |
News Archive
A study by the UPV/EHU has found that undocumented immigrants encounter structural and individual barriers linked to their social vulnerability when accessing public health services in the Basque Autonomous Community.
Amgen today announced top-line results of the Phase 3 EVOLVE (EValuation Of Cinacalcet HCl Therapy to Lower CardioVascular Events) trial, which evaluated Sensipar/Mimpara (cinacalcet) for the reduction of the risk of mortality and cardiovascular (CV) events among 3,883 patients with secondary hyperparathyroidism (HPT) and chronic kidney disease (CKD) receiving dialysis.
In a study published today in Genes & Development, Dr Christian Speck from the MRC Clinical Sciences Centre's DNA Replication group, in collaboration with Brookhaven National Laboratory (BNL), New York, reveal the intricate mechanisms involved in the enzyme that governs DNA duplication during cell division.
In an article in its "Building Resilience" series, IRIN examines the impact of HIV funding on health care systems in developing countries, writing, "Some have argued that the AIDS epidemic has helped generate an overall increase in health funding and mobilized an international push for more equitable health care access. But others maintain that the billions of donor dollars spent fighting HIV/AIDS in the last decade have done little to strengthen fragile national health systems."
› Verified 1 days ago
Alexandria Kidney Center Location: 4141 Duke Street, Alexandria, Virginia, 22304 Phone: (703) 370-8250 |
Franconia Dialysis Center Location: 5695 King Center Dr, Alexandria, Virginia, 22315 Phone: (703) 921-9506 |
News Archive
A study by the UPV/EHU has found that undocumented immigrants encounter structural and individual barriers linked to their social vulnerability when accessing public health services in the Basque Autonomous Community.
Amgen today announced top-line results of the Phase 3 EVOLVE (EValuation Of Cinacalcet HCl Therapy to Lower CardioVascular Events) trial, which evaluated Sensipar/Mimpara (cinacalcet) for the reduction of the risk of mortality and cardiovascular (CV) events among 3,883 patients with secondary hyperparathyroidism (HPT) and chronic kidney disease (CKD) receiving dialysis.
In a study published today in Genes & Development, Dr Christian Speck from the MRC Clinical Sciences Centre's DNA Replication group, in collaboration with Brookhaven National Laboratory (BNL), New York, reveal the intricate mechanisms involved in the enzyme that governs DNA duplication during cell division.
In an article in its "Building Resilience" series, IRIN examines the impact of HIV funding on health care systems in developing countries, writing, "Some have argued that the AIDS epidemic has helped generate an overall increase in health funding and mobilized an international push for more equitable health care access. But others maintain that the billions of donor dollars spent fighting HIV/AIDS in the last decade have done little to strengthen fragile national health systems."
› Verified 1 days ago